Structure via PubChem · Public domain (PubChem)
vanoxerine
Sign in to saveAlso known as GBR 12909, GBR12909, 1-{2-[bis(p-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine
Vanoxerine is an investigational drug which is being evaluated for the treatment of heart arrhythmias and cocaine dependence. Vanoxerine is a piperazine derivative which has multiple pharmacological activities including acting as an dopamine reuptake inhibitor, serotonin transporter inhibitor, and as a blocker of the cardiac hERG repolarizing potassium channel (IKr).
In the Vinony graph
Vinony's link graph records 1,454 inbound references to vanoxerine, and connects out to valproic acid, conotoxin and heart arrhythmia.
Vinony files it under 1-(2-(Bis(4-fluorophenyl)methoxy)ethyl)piperazines, 4-Fluorophenyl compounds and Chemical articles with multiple CAS registry numbers.
Vinony links it to 5 Wikipedia language editions.
Chemical data
- Formula
- C28H32F2N2O
- Molecular weight
- 450.6 g/mol
- IUPAC name
- 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine
- SMILES
- C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
- InChIKey
- NAUWTFJOPJWYOT-UHFFFAOYSA-N
- XLogP
- 5.6
- Polar surface area
- 15.7 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 3
- Molecule type
- Small molecule
- Indications
- atrial fibrillation, atrial flutter, cocaine dependence, cocaine abuse
via ChEMBL · EBI
Research
530 papersvia PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 450.24827
Show 5 more facts
- chemical formula
- C₂₈H₃₂F₂N₂O
- canonical SMILES
- C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
- World Health Organisation international non-proprietary name
- vanoxerine
- subject has role
- dopamine reuptake inhibitor
- Commons category
- Vanoxerine
Sources (2)
via Wikidata · CC0
~7 min read
Encyclopedic overview
12 sectionsContents
- Research
- Treatment of cocaine dependence
- Antiarrhythmic
- Miscellaneous
- Pharmacology
- Mechanism of action
- Society and culture
- History
- Chemistry
- Synthesis
- See also
- References
Vanoxerine is an investigational drug which is being evaluated for the treatment of heart arrhythmias and cocaine dependence. Vanoxerine is a piperazine derivative which has multiple pharmacological activities including acting as an dopamine reuptake inhibitor, serotonin transporter inhibitor, and as a blocker of the cardiac hERG repolarizing potassium channel (IKr).
== Research ==
Excerpted from Wikipedia’s “vanoxerine” article, available under the CC BY-SA 4.0 licence.